AKRX - Akorn
Earnings Results
Results > 2019 > AKRX

Akorn ( AKRX )

Recent earnings result

  1. EPS beats by $0.06, revenue in-line
  2. Up 2% on preliminary Q3 results

Supporting docs

  1. Listen to webcast
  2. PDF document

Top Stories (AKRX)

Events & Annual meetings

Title Date Webcast
Q3 2019 Akorn, Inc. Earnings Conference Call 10/31/19 10:00 AM EDT edge.media-server.com webcast
akorn.com PDF
Q2 2019 Akorn, Inc. Earnings Conference Call 08/01/19 9:00 AM EDT edge.media-server.com webcast
Akorn, Inc. at Jefferies 2019 Global Healthcare Conference 06/07/19 9:30 AM EDT wsw.com webcast
Akorn, Inc. at 2019 RBC Capital Markets Healthcare Conference 05/22/19 2:05 PM EDT veracast.com webcast
Q4 2018 Akorn, Inc. Earnings Conference Call 02/28/19 10:00 AM EST edge.media-server.com webcast
Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

For more information you may also visit their official Investor Relations website.


Akorn, Inc. is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals and branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.



Recent results

Books we are reading